2013
DOI: 10.1111/ejn.12326
|View full text |Cite
|
Sign up to set email alerts
|

Aging and neurogenesis in the adult forebrain: what we have learned and where we should go from here

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
14
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 2 publications
3
14
0
Order By: Relevance
“…The aim of this approach was to identify key transcriptional changes underlying the decline in the activity and loss of competence of NSCs that occurs in adulthood, which is attributed to the combined up-regulation of inhibitory and down-regulation of positive cues [30], and is critical for the response of NSCs to brain injury and degeneration [31,32]. In this manner, key small molecules were identified for “rejuvenating” adult NSC (Fig 2E; Table 1D), approximately 20% of which overlapped with those required in dorsalizing or ventralizing the postnatal SVZ, and were categorized as “Receptor antagonist,” “Signaling,” and “Metabolism.” Some interesting candidates included antagonists for α/β adrenergic receptors, including the highly ranked nadolol (Table 1D), which have been described to promote NSC activation from quiescence in the dentate gyrus [33] and enhance NP survival following exit from the SVZ [34].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The aim of this approach was to identify key transcriptional changes underlying the decline in the activity and loss of competence of NSCs that occurs in adulthood, which is attributed to the combined up-regulation of inhibitory and down-regulation of positive cues [30], and is critical for the response of NSCs to brain injury and degeneration [31,32]. In this manner, key small molecules were identified for “rejuvenating” adult NSC (Fig 2E; Table 1D), approximately 20% of which overlapped with those required in dorsalizing or ventralizing the postnatal SVZ, and were categorized as “Receptor antagonist,” “Signaling,” and “Metabolism.” Some interesting candidates included antagonists for α/β adrenergic receptors, including the highly ranked nadolol (Table 1D), which have been described to promote NSC activation from quiescence in the dentate gyrus [33] and enhance NP survival following exit from the SVZ [34].…”
Section: Resultsmentioning
confidence: 99%
“…Analysis of BAT-gal mice [41] further demonstrated a decline in Wnt/β-catenin activity between P6 and P60, together with a decrease in the densities of Tbr2+ NPs and to a lesser extent Olig2+ OPs in the adult and their apparent loss by P120 (Fig 6B and 6C). These analyses reveal that the neurogenic capacity and lineage diversity of the dSVZ declines in the adult brain [30,42] and, based on the SPIED/CMAP analysis, we predicted GSK3β inhibitors are strong candidates for rejuvenating the adult dSVZ.…”
Section: Resultsmentioning
confidence: 99%
“…The NSCs ensure brain homeostasis, repair, and neuroregeneration in the adult, but undergo proliferation and differentiation decline with age. The decreased neurogenesis correlates and contributes to age‐related disorders in the human and in mouse model, and it is thought to be due to the senescence of progenitor cells. Diverse stimuli can induce senescence in NSCs in vitro, including DNA damage, oxidative stress, and activated oncogenes .…”
Section: Senescence In the Brain And Its Physiological Rolementioning
confidence: 99%
“…In addition, following neural damage, NSC-derived progeny are re-directed to areas of degeneration, where they are involved in wound healing and cell replacement and can serve as a target for therapeutic manipulations (Benner et al, 2013;de Chevigny et al, 2008;Erlandsson et al, 2011;Kolb et al, 2007). NSC activity decreases naturally during aging and is dysregulated in models of neurodegenerative diseases, suggesting an involvement in aging-and disease-associated cognitive deficits (Bouab et al, 2011;Demars et al, 2010;Hamilton et al, 2010;Hamilton et al, 2013;Lazarov and Marr, 2010;. Consistent with this, disturbances in neurogenesis have been reported in Alzheimer's disease (AD) patients (Crews et al, 2010;Perry et al, 2012;Ziabreva et al, 2006) and a range of AD transgenic mouse models (Chuang, 2010;Hamilton et al, 2010).…”
Section: Introductionmentioning
confidence: 99%